National HealthCare (NHC) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 Jul, 2026Executive summary
Net operating revenues for Q3 2025 increased 12.5% year-over-year, driven by an 8.7% rise in same-facility revenues and the White Oak acquisition.
GAAP net income attributable to stockholders was $39.2M for Q3 2025, down from $42.8M in Q3 2024, but adjusted net income rose 24.3% to $24.7M, reflecting core operational improvements.
Skilled nursing facility census improved to 90.0% in Q3 2025 from 88.3% a year ago, with continued focus on occupancy and labor cost management.
Financial highlights
Q3 2025 net operating revenues: $382.7M, up from $340.2M in Q3 2024.
Net income attributable to stockholders for Q3 2025: $39.2M; nine months YTD: $95.2M.
Adjusted net income for Q3 2025: $24.7M, up from $19.9M in Q3 2024; nine months YTD: $75.3M, up from $50.9M.
Diluted EPS for Q3 2025: $2.50; nine months YTD: $6.10.
Cash and equivalents at period end: $130.6M; unrestricted marketable equity securities: $166.8M.
Outlook and guidance
Management expects to meet short- and long-term liquidity needs through operating cash flows, cash on hand, and available credit.
Medicare and Medicaid rate increases in key states are expected to boost annual revenues by $7.2M starting in Q4 2025.
Ongoing focus on occupancy, labor cost control, and integration of White Oak operations.
Latest events from National HealthCare
- Strong revenue and earnings growth, major acquisition, and new credit facility drive expansion.NHC
Q2 20243 Jul 2026 - 2024 net income surged 52.6% on 14.5% revenue growth, boosted by the White Oak acquisition.NHC
Q4 20243 Jul 2026 - 2025 revenues grew 16.1% to $1.52B, net income reached $120M, and occupancy improved.NHC
Q4 20253 Jul 2026 - Annual meeting to vote on director re-elections, say-on-pay, and review robust governance and ESG.NHC
Proxy filing3 Jul 2026 - Q3 2024 revenue and net income surged on rate hikes and the White Oak acquisition, with improved margins.NHC
Q3 20243 Jul 2026 - Revenue and earnings surged on acquisition and census gains, with strong liquidity and margin improvement.NHC
Q1 20253 Jul 2026 - Q2 2025 revenues surged 24.7% year-over-year, with adjusted net income up 64.7%.NHC
Q2 20253 Jul 2026 - Q1 2026 net income rose 11% to $35.9M; $560M facility acquisition announced for Q3 close.NHC
Q1 20263 Jul 2026 - 2026 proxy details director elections, say-on-pay, auditor change, and strong ESG focus.NHC
Proxy filing3 Jul 2026